Status:
COMPLETED
Comparison of Conventionally Manufactured AFO and Modular Customized AFO
Lead Sponsor:
Beat Göpfert
Conditions:
Gait, Drop Foot
Eligibility:
All Genders
11-65 years
Phase:
NA
Brief Summary
The Investigator will investigate the difference in the gait pattern between 2 commercially available ankle foot orthoses (AFO): a) conventionally manufactured AFO and b) modular customized AFO using ...
Detailed Description
Cerebral palsy (CP) is the most common movement disorder in children \[Stavsky, 2017\]. It is frequently accompanied by spasticity \[Baker, 2009\]. The typical symptoms of spastic cerebral palsy are g...
Eligibility Criteria
Inclusion
- Participants fulfilling all of the following inclusion criteria are eligible for the study:
- Patients (11-18 yrs.), who need a new orthosis (visit to an orthopedic technician)
- Patients (18-65 yrs.), who need a new orthosis (visit to an orthopedic technician)
- Informed Consent provided as documented by signature
- Confirmed diagnosis of cerebral palsy
- Confirmed diagnosis of spastic equinus and/ or drop foot,
- Gait pathologies treated with conventional AFO
- Gross Motor Function Classification System (GMFCS) level I or II
Exclusion
- Other neuromuscular diseases
- Surgical intervention lower extremities past 12 months to improve gait pathologies
- Injections of Botulinum toxin 6 months prior to study inclusion
- Inability or unwillingness to follow the procedures of the gait analysis
- in women: pregnancy
Key Trial Info
Start Date :
February 25 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2024
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT05192915
Start Date
February 25 2022
End Date
January 31 2024
Last Update
December 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Basel
Basel, Canton of Basel-City, Switzerland, 4000